Results 121 to 130 of about 9,451 (197)
Patient outcomes in KCNQ2 developmental and epileptic encephalopathy
Abstract The aim of this study was to review and summarize the literature describing clinically observed or caregiver‐reported and patient‐reported KCNQ2 developmental and epileptic encephalopathy (DEE) outcomes. Three online databases and selected congress proceedings were searched (August 2023).
Grant Maclaine +9 more
wiley +1 more source
ABSTRACT Background The recent approval of disease‐modifying therapies (DMTs) for early Alzheimer's disease (AD) marks a major shift in clinical practice. Biomarker confirmation of amyloid pathology is now required alongside clinical assessment, and blood‐based tests are improving accessibility.
Tim Van Langenhove +31 more
wiley +1 more source
Presentation of Bilateral Optic Disc Coloboma-Morning Glory Syndrome in Mother and Son, with Retinitis Pigmentosa in the Father. [PDF]
İslambekov Y, Çakır B, Ateş K.
europepmc +1 more source
Etiologic spectrum and predictors of visual acuity in non-glaucomatous optic atrophy. [PDF]
Sharifi M, Zand A, Sharifi M, Sharifi A.
europepmc +1 more source
ATP1A3-related syndromes: our case-series unveiling a dynamic, fever-triggered and overlapping array of neurological phenotypes. [PDF]
Errichiello G +10 more
europepmc +1 more source
Rhesus macaques with an <i>OPA1</i> mutation demonstrate features of autosomal dominant optic atrophy. [PDF]
Jaggers TN +27 more
europepmc +1 more source

